Chemistry of the bleomycin-induced alkali-labile DNA lesion

Journal of the American Chemical Society

Volumn 121, Issue 39, 1999, Pages 9023-9033

  Aso, Mariko ^a,b   Kondo, Mitsumasa ^a   Suemune, Hiroshi ^a   Hecht, Sidney M ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; BUTYLAMINE; DINUCLEOTIDE; DNA FRAGMENT; LACTAM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DNA DAMAGE; DNA DEGRADATION; DRUG MECHANISM; PH; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0032878569     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja991574a     Document Type: Article

References (65)

1. (a) Hecht, S. M. In Bleomycin: Chemical, Biochemical and Biological Aspects; Hecht, S. M., Ed.; Springer-Verlag: New York, 1979; p 1ff.
2. (b) Umezawa, H. In Medicinal Chemistry Series: Anticancer Agents Based on Natural Product Models; Cassady, J. M., Dourous, J. D., Eds.; Academic Press: New York, 1980; Vol. XVI, p 148ff.
3. (c) Povirk, L. F. In Molecular Aspects of Anticancer Drug Action; Neidle, S., Waring, M. J., Eds.; Macmillan: London, 1983; p 157ff.
4. (d) Stubbe, J.; Kozarich, J. W. Chem. Rev. 1987, 87, 1107.
5. (e) Natrajan, A.; Hecht, S. M. In Molecular Aspects of Anticancer Drug-DNA Interaction; Neidle, S., Waring, M. J., Eds.; MacMillan Press: London, 1993; p 197.
6. (f) Kane, S. A.; Hecht, S. M. Prog. Nucleic Acid Res. Mol. Biol. 1994, 49, 313.
7. (g) Hecht, S. M. In Cancer Chemotherapeutic Agents; Foye, W. O., Ed.; American Chemical Society: Washington, DC, 1995; p 369ff.
8. (a) Umezawa, H. In Bleomycin: Current Status and New Developments; Carter, S. K., Crooke, S. T., Umezawa, H., Eds.; Academic Press: New York, 1978.
9. (b) Bleomycin Chemotherapy; Sikic, B. I., Rozencweig, M., Carter, S. K., Eds.; Academic Press: Orlando, FL, 1985.
10. (a) Ishida, R.; Takahashi, T. Biochem. Biophys. Res. Commun. 1975, 66, 1432.
11. (b) Sausville, E. A.; Stein, R. W.; Peisach, J.; Horwitz, S. B. Biochemistry 1978, 17, 2740.
12. (c) Sausville, E. A.; Stein, R. W.; Peisach, J.; Horwitz, S. B. Biochemistry 1978, 17, 2746.
13. (a) Twentyman, P. R. Pharm. Ther. 1984, 23, 417.
14. (b) Petering, D. H.; Byrnes, R. W.; Antholine, W. E. Chem. Biol. Interact. 1990, 73, 1333.
15. (c) Fox, K. R. Anti-Cancer Drug Des. 1990, 5, 99.
16. (d) Murphy, J. A.; Griffiths, J. Nat. Prod. Rep. 1993, 551.
17. (a) Carter, B. J.; de Vroom, E.; Long, E. C.; van der Marel, G. A.; van Boom, J. H.; Hecht, S. M. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 9373.
18. (b) Carter, B. J.; Reddy, K. S.; Hecht, S. M. Tetrahedron 1991, 47, 2463.
19. (c) Holmes, C. E., Carter, B. J.; Hecht, S. M. Biochemistry 1993, 32, 4293.
20. (d) Hecht, S. M. Bioconj. Chem. 1994, 5, 513.
21. (e) Holmes, C. E.; Duff, R. J.; van der Marel, G. A.; van Boom, J.; Hecht, S. M. Bioorg. Med. Chem. 1997, 5, 1235.
22. (f) Hecht, S. M. In The Many Faces of RNA; Eggleston, D. S., Prescott, C. D., Pearson, N. D., Eds.; Academic Press Ltd.: London, 1998; p 3ff.
23. (a) Kuramochi, H.; Takahashi, K.; Takita, T.; Umezawa, H. J. Antibiot. 1981, 34, 576.
24. (b) Barr, J. R.; Van Atta, R. B.; Natrajan, A.; Hecht, S. M. J. Am. Chem. Soc. 1990, 112, 4058.
25. (a) D'Andrea, A. D.; Haseltine, W. A. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 3608.
26. (b) Takeshita, M.; Grollman, A. P.; Ohtsubo, E.; Ohtsubo, H. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 5983.
27. (c) Mirabelli, C. K.; Ting, A.; Huang, C.-H.; Mong, S.; Crooke S. T. Cancer Res. 1982, 42, 2779.
28. (d) Kross, J.; Henner, W. D.; Hecht, S. M.; Haseltine, W. A. Biochemistry 1982, 21, 4310.
29. (e) Long, E. C.; Hecht, S. M.; van der Marel, G. A.; van Boom, J. H. J. Am. Chem. Soc. 1990, 112, 5272.
30. (a) Burger, R. M.; Berkowitz, A. R.; Peisach, J.; Horwitz, S. B. J. Biol. Chem. 1980, 255, 11832.
31. (b) Giloni, L.; Takeshita, M.; Johnson, F.; Iden, C.; Grollman, A. P. J. Biol. Chem. 1981, 256, 8608.
32. (c) Uesugi, S.; Shida, T.; Ikehara, M.; Kobayashi, Y.; Kyogoku, Y. Nucleic Acids Res. 1984, 12, 1581.
33. (d) Sugiyama, H.; Ehrenfeld, G. M.; Shipley, J. B.; Kilkuskie, R. E.; Chang, L.-H.; Hecht, S. M. J. Nat. Prod. 1985, 48, 869.
34. (e) Sugiyama, H.; Kilkuskie, R. E.; Hecht, S. M.; van der Marel, G. A.; van Boom, J. H. J. Am. Chem. Soc. 1985, 107, 7765.
35. (f) Murugesan, N.; Xu, C.; Ehrenfeld, G. M.; Sugiyama, H.; Kilkuskie, R. E.; Rodriguez, L. O.; Chang, L.-H.; Hecht, S. M. Biochemistry 1985, 24, 5735.
36. (g) Sugiyama, H.; Kilkuskie, R. E.; Chang, L.-H.; Ma, L.-T.; Hecht, S. M. J. Am. Chem. Soc. 1986, 108, 3852.
37. (a) Burger, R. M.; Peisach, J.; Horwitz, S. B. J. Biol. Chem. 1982, 257, 8612.
38. (b) Wu, J. C.; Kozarich, J. W.; Stubbe, J. J. Biol. Chem. 1983, 258, 4694.
39. (c) Wu, J. C.; Kozarich, J. W.; Stubbe, J. Biochemistry 1985, 24, 7562.
40. (d) Wu, J. C.; Kozarich, J. W.; Stubbe, J. Biochemistry 1985, 24, 7569.
41. (e) Sugiyama, H.; Xu, C.; Murugesan, N.; Hecht, S. M. J. Am. Chem. Soc. 1985, 107, 4104.
42. (f) Rabow, L. E.; Stubbe, J.; Kozarich, J. W.; Gerlt, J. A. J. Am. Chem. Soc. 1986, 108, 7130.
43. (g) Sugiyama, H.; Xu, C.; Murugesan, N.; Hecht, S. M.; van der Marel, G. A.; van Boom, J. H. Biochemistry 1988, 27, 58.
44. (h) Rabow, L.; Stubbe, J.; Kozarich, J. W. J. Am. Chem. Soc. 1990, 112, 3196.
45. (i) Rabow, L.; McGall, G. H.; Stubbe, J.; Kozarich, J. W. J. Am. Chem. Soc. 1990, 112, 3203.
46. Scheffold, R.; Dubs, P. Helv. Chim. Acta 1967, 50, 798.
47. (a) Palm, V. A.; Haldna, U. L.; Talvik, A. J. In The Chemistry of the Carbonyl Groups: Basicity of Carbonyl Compounds; Patai, S., Ed.; John Wiley and Sons: New York, 1966; p 421ff.
48. (b) Dayagi, S.; Degani, Y. In The Chemistry of the Carbon-Nitrogen Double Bond: Methods of Formation of the Carbon-Nitrogen Double Bond; Patai, S., Ed.; John Wiley and Sons: New York, 1970; p 61ff.
49. (a) Johnson, F.; Pillai, K. M. R.; Grollman, A. P.; Tseng, L.; Takeshita, M. J. Med. Chem. 1984, 27, 954.
50. (b) Grollman, A. P.; Takeshita, M.; Pillai, K. M. R.; Johnson, F. Cancer Res. 1985, 45, 1127.
51. (c) Grollman, A. P. Dev. Oncol. 1988, 53, 79.
52. D'Alelio, G. F.; Williams, C. J.; Wilson, C. L. J. Org. Chem. 1960, 25, 1025.
53. The low yield of lactam observed under basic conditions was found to be due to its instability under the reaction conditions. Amine treatment of authentic 15 resulted in considerable decomposition and 15 was recovered only in 14% yield. This indicated that lactam formation under basic conditions may also proceed via the mechanism shown in Scheme 7 although the yield of 15 was low.
54. Van Atta, R. B.; Long, E. C.; Hecht, S. M. J. Am. Chem. Soc. 1989, 111, 2722.
55. (a) Miller, M. R.; Chinault, D. N. J. Biol. Chem. 1982, 257, 10204.
56. (b) Seki, S.; Oda, T. Carcinogenesis 1986, 7, 77.
57. (c) Seki, S.; Oda, T. Carcinogensis 1988, 9, 2239.
58. (d) DiGiuseppe, J. A.; Dresler, S. L. Biochemistry 1989, 28, 9515.
59. (e) Park, I.-S.; Koh, H. Y.; Park, J. K.; Park, S. D. Biochem. Biophys. Res. Commun. 1989, 164, 1226.
60. (f) Zhang, B.; Seki, S.; Ikeda, S. Int. J. Biochem. 1982, 23, 703.
61. (a) Matsumoto, Y.; Kim, K.; Katz, D. S.; Feng, J.-A. Biochemistry 1998, 37, 6456.
62. (b) Feng, J.-A.; Crasto, C. J.; Matsumoto, Y. Biochemistry 1998, 37, 9605.
63. (c) Prasad, R.; Beard, W. A.; Strauss, P. R.; Wilson, S. H. J. Biol. Chem. 1998, 273, 15263.
64. Achmatowicz, O., Jr.; Bakowski, P.; Szechner, B.; Zwierzchowska, Z.; Zamojski, A. Tetrahedron 1971, 27, 1973.
65. Clauson-Kaas, N.; Dietrich, P.; Nielsen, J. T. Acta Chem. Scand. 1953, 7, 845.